RxDoctor Payments Data

Michael Aranda, DO

Family Medicine · Cottonwood, AZNPI 1922065127

Payments from drug & device makers

$1,378in general payments, 2019–2025

Across 73 payments — averaging $18.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$552
  • Pfizer$246
  • Paratek Pharmaceuticals, Inc.$154
  • Amgen$77
  • Medtronic$61
  • Lilly USA, LLC$49
  • plus $239 from 12 others

What the payments were for

  • Food & beverage$1,378100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,378 in reported general payments places this provider in the 75th percentile of 2,099 family medicine providers in Arizona.

See all family medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$217,821
Medicare patients
365
Services billed
2,108

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban82$85,321
FarxigaDapagliflozin Propanediol55$52,347
OzempicSemaglutide20$37,914
JardianceEmpagliflozin48$34,056
XareltoRivaroxaban25$27,221
Breztri AerosphereBudesonide/Glycopyr/Formoterol20$21,465
Breo ElliptaFluticasone/Vilanterol37$17,831
JanuviaSitagliptin Phosphate11$17,167
MounjaroTirzepatide14$14,528
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$13,295
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog15$8,025
Spiriva HandihalerTiotropium Bromide11$6,717
Buprenorphine15$6,073
MyrbetriqMirabegron16$5,588
Potassium Chloride71$4,024

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$246$88,05695 claims
AstraZenecaFarxiga, Breztri Aerosphere$552$73,81275 claims
Novo NordiskOzempic, Novolog$40$39,48131 claims
GSKBreo Ellipta, Trelegy Ellipta$13$31,12656 claims
Johnson & JohnsonXarelto$12$27,22125 claims
Lilly USA, LLCMounjaro$49$14,52814 claims
Astellas Pharma US IncMyrbetriq$20$5,58816 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,099 family medicine providers in Arizona.

Other family medicine in Cottonwood

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →